ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Assisted Reproductive Technologies Medications Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-23U12672
Home | Market Reports | Health| Reproductive Health
Global Assisted Reproductive Technologies Medications Market Research Report 2023
BUY CHAPTERS

Global Assisted Reproductive Technologies Medications Market Research Report 2025

Code: QYRE-Auto-23U12672
Report
May 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ipsen S A
Ferring
Organon
Solvay S A
Besins
Zhejiang Xianju
Changchun GeneScience
Hybio Pharmaceutical
Livzon Pharmaceutical
Merck Serono

Assisted Reproductive Technologies Medications Market Size

The global market for Assisted Reproductive Technologies Medications was valued at US$ 13300 million in the year 2024 and is projected to reach a revised size of US$ 20550 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Assisted Reproductive Technologies Medications Market

Assisted Reproductive Technologies Medications Market

Assisted reproductive technology (ART) is used to treat infertility. It includes fertility treatments that handle both eggs and sperm. A number of different agents are used to achieve controlled ovarian hyperstimulation. These include clomiphene, GnRH analogues, menotropins, urofollitropin, highly purified FSH, and recombinant human FSH (rh-FSH), etc.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Assisted Reproductive Technologies Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Technologies Medications.
The Assisted Reproductive Technologies Medications market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Assisted Reproductive Technologies Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Assisted Reproductive Technologies Medications companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Assisted Reproductive Technologies Medications Market Report

Report Metric Details
Report Name Assisted Reproductive Technologies Medications Market
Accounted market size in year US$ 13300 million
Forecasted market size in 2031 US$ 20550 million
CAGR 6.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck Serono, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju, Changchun GeneScience, Hybio Pharmaceutical, Livzon Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Assisted Reproductive Technologies Medications company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Assisted Reproductive Technologies Medications Market growing?

Ans: The Assisted Reproductive Technologies Medications Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Assisted Reproductive Technologies Medications Market size in 2031?

Ans: The Assisted Reproductive Technologies Medications Market size in 2031 will be US$ 20550 million.

Who are the main players in the Assisted Reproductive Technologies Medications Market report?

Ans: The main players in the Assisted Reproductive Technologies Medications Market are Merck Serono, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju, Changchun GeneScience, Hybio Pharmaceutical, Livzon Pharmaceutical

What are the Application segmentation covered in the Assisted Reproductive Technologies Medications Market report?

Ans: The Applications covered in the Assisted Reproductive Technologies Medications Market report are Hospital Pharmacy, Specialty & Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Assisted Reproductive Technologies Medications Market report?

Ans: The Types covered in the Assisted Reproductive Technologies Medications Market report are Down-Regulation Drugs, Ovulation Stimulation Drugs, Ovulation Inducing Drugs, Luteal Support Medications

Recommended Reports

Reproductive Treatments

Hormonal Therapy

Genitourinary Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Down-Regulation Drugs
1.2.3 Ovulation Stimulation Drugs
1.2.4 Ovulation Inducing Drugs
1.2.5 Luteal Support Medications
1.3 Market by Application
1.3.1 Global Assisted Reproductive Technologies Medications Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Specialty & Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Assisted Reproductive Technologies Medications Market Perspective (2020-2031)
2.2 Global Assisted Reproductive Technologies Medications Growth Trends by Region
2.2.1 Global Assisted Reproductive Technologies Medications Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Assisted Reproductive Technologies Medications Historic Market Size by Region (2020-2025)
2.2.3 Assisted Reproductive Technologies Medications Forecasted Market Size by Region (2026-2031)
2.3 Assisted Reproductive Technologies Medications Market Dynamics
2.3.1 Assisted Reproductive Technologies Medications Industry Trends
2.3.2 Assisted Reproductive Technologies Medications Market Drivers
2.3.3 Assisted Reproductive Technologies Medications Market Challenges
2.3.4 Assisted Reproductive Technologies Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Assisted Reproductive Technologies Medications Players by Revenue
3.1.1 Global Top Assisted Reproductive Technologies Medications Players by Revenue (2020-2025)
3.1.2 Global Assisted Reproductive Technologies Medications Revenue Market Share by Players (2020-2025)
3.2 Global Assisted Reproductive Technologies Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Assisted Reproductive Technologies Medications Revenue
3.4 Global Assisted Reproductive Technologies Medications Market Concentration Ratio
3.4.1 Global Assisted Reproductive Technologies Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Assisted Reproductive Technologies Medications Revenue in 2024
3.5 Global Key Players of Assisted Reproductive Technologies Medications Head office and Area Served
3.6 Global Key Players of Assisted Reproductive Technologies Medications, Product and Application
3.7 Global Key Players of Assisted Reproductive Technologies Medications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Assisted Reproductive Technologies Medications Breakdown Data by Type
4.1 Global Assisted Reproductive Technologies Medications Historic Market Size by Type (2020-2025)
4.2 Global Assisted Reproductive Technologies Medications Forecasted Market Size by Type (2026-2031)
5 Assisted Reproductive Technologies Medications Breakdown Data by Application
5.1 Global Assisted Reproductive Technologies Medications Historic Market Size by Application (2020-2025)
5.2 Global Assisted Reproductive Technologies Medications Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Assisted Reproductive Technologies Medications Market Size (2020-2031)
6.2 North America Assisted Reproductive Technologies Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Assisted Reproductive Technologies Medications Market Size by Country (2020-2025)
6.4 North America Assisted Reproductive Technologies Medications Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Assisted Reproductive Technologies Medications Market Size (2020-2031)
7.2 Europe Assisted Reproductive Technologies Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Assisted Reproductive Technologies Medications Market Size by Country (2020-2025)
7.4 Europe Assisted Reproductive Technologies Medications Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Assisted Reproductive Technologies Medications Market Size (2020-2031)
8.2 Asia-Pacific Assisted Reproductive Technologies Medications Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Region (2020-2025)
8.4 Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Assisted Reproductive Technologies Medications Market Size (2020-2031)
9.2 Latin America Assisted Reproductive Technologies Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Assisted Reproductive Technologies Medications Market Size by Country (2020-2025)
9.4 Latin America Assisted Reproductive Technologies Medications Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Assisted Reproductive Technologies Medications Market Size (2020-2031)
10.2 Middle East & Africa Assisted Reproductive Technologies Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2020-2025)
10.4 Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Serono
11.1.1 Merck Serono Company Details
11.1.2 Merck Serono Business Overview
11.1.3 Merck Serono Assisted Reproductive Technologies Medications Introduction
11.1.4 Merck Serono Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.1.5 Merck Serono Recent Development
11.2 Ipsen
11.2.1 Ipsen Company Details
11.2.2 Ipsen Business Overview
11.2.3 Ipsen Assisted Reproductive Technologies Medications Introduction
11.2.4 Ipsen Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.2.5 Ipsen Recent Development
11.3 Ferring
11.3.1 Ferring Company Details
11.3.2 Ferring Business Overview
11.3.3 Ferring Assisted Reproductive Technologies Medications Introduction
11.3.4 Ferring Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.3.5 Ferring Recent Development
11.4 Organon
11.4.1 Organon Company Details
11.4.2 Organon Business Overview
11.4.3 Organon Assisted Reproductive Technologies Medications Introduction
11.4.4 Organon Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.4.5 Organon Recent Development
11.5 Solvay
11.5.1 Solvay Company Details
11.5.2 Solvay Business Overview
11.5.3 Solvay Assisted Reproductive Technologies Medications Introduction
11.5.4 Solvay Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.5.5 Solvay Recent Development
11.6 Besins
11.6.1 Besins Company Details
11.6.2 Besins Business Overview
11.6.3 Besins Assisted Reproductive Technologies Medications Introduction
11.6.4 Besins Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.6.5 Besins Recent Development
11.7 Zhejiang Xianju
11.7.1 Zhejiang Xianju Company Details
11.7.2 Zhejiang Xianju Business Overview
11.7.3 Zhejiang Xianju Assisted Reproductive Technologies Medications Introduction
11.7.4 Zhejiang Xianju Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.7.5 Zhejiang Xianju Recent Development
11.8 Changchun GeneScience
11.8.1 Changchun GeneScience Company Details
11.8.2 Changchun GeneScience Business Overview
11.8.3 Changchun GeneScience Assisted Reproductive Technologies Medications Introduction
11.8.4 Changchun GeneScience Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.8.5 Changchun GeneScience Recent Development
11.9 Hybio Pharmaceutical
11.9.1 Hybio Pharmaceutical Company Details
11.9.2 Hybio Pharmaceutical Business Overview
11.9.3 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Introduction
11.9.4 Hybio Pharmaceutical Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.9.5 Hybio Pharmaceutical Recent Development
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Details
11.10.2 Livzon Pharmaceutical Business Overview
11.10.3 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Introduction
11.10.4 Livzon Pharmaceutical Revenue in Assisted Reproductive Technologies Medications Business (2020-2025)
11.10.5 Livzon Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Ipsen S A
Ferring
Organon
Solvay S A
Besins
Zhejiang Xianju
Changchun GeneScience
Hybio Pharmaceutical
Livzon Pharmaceutical
Merck Serono
List of Tables
 Table 1. Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Down-Regulation Drugs
 Table 3. Key Players of Ovulation Stimulation Drugs
 Table 4. Key Players of Ovulation Inducing Drugs
 Table 5. Key Players of Luteal Support Medications
 Table 6. Global Assisted Reproductive Technologies Medications Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Assisted Reproductive Technologies Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Assisted Reproductive Technologies Medications Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Assisted Reproductive Technologies Medications Market Share by Region (2020-2025)
 Table 10. Global Assisted Reproductive Technologies Medications Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Assisted Reproductive Technologies Medications Market Share by Region (2026-2031)
 Table 12. Assisted Reproductive Technologies Medications Market Trends
 Table 13. Assisted Reproductive Technologies Medications Market Drivers
 Table 14. Assisted Reproductive Technologies Medications Market Challenges
 Table 15. Assisted Reproductive Technologies Medications Market Restraints
 Table 16. Global Assisted Reproductive Technologies Medications Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Assisted Reproductive Technologies Medications Market Share by Players (2020-2025)
 Table 18. Global Top Assisted Reproductive Technologies Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproductive Technologies Medications as of 2024)
 Table 19. Ranking of Global Top Assisted Reproductive Technologies Medications Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Assisted Reproductive Technologies Medications Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Assisted Reproductive Technologies Medications, Headquarters and Area Served
 Table 22. Global Key Players of Assisted Reproductive Technologies Medications, Product and Application
 Table 23. Global Key Players of Assisted Reproductive Technologies Medications, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Assisted Reproductive Technologies Medications Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Assisted Reproductive Technologies Medications Revenue Market Share by Type (2020-2025)
 Table 27. Global Assisted Reproductive Technologies Medications Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Assisted Reproductive Technologies Medications Revenue Market Share by Type (2026-2031)
 Table 29. Global Assisted Reproductive Technologies Medications Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Assisted Reproductive Technologies Medications Revenue Market Share by Application (2020-2025)
 Table 31. Global Assisted Reproductive Technologies Medications Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Assisted Reproductive Technologies Medications Revenue Market Share by Application (2026-2031)
 Table 33. North America Assisted Reproductive Technologies Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Assisted Reproductive Technologies Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Assisted Reproductive Technologies Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Assisted Reproductive Technologies Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Assisted Reproductive Technologies Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Assisted Reproductive Technologies Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Assisted Reproductive Technologies Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Assisted Reproductive Technologies Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Assisted Reproductive Technologies Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Assisted Reproductive Technologies Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Merck Serono Company Details
 Table 49. Merck Serono Business Overview
 Table 50. Merck Serono Assisted Reproductive Technologies Medications Product
 Table 51. Merck Serono Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 52. Merck Serono Recent Development
 Table 53. Ipsen Company Details
 Table 54. Ipsen Business Overview
 Table 55. Ipsen Assisted Reproductive Technologies Medications Product
 Table 56. Ipsen Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 57. Ipsen Recent Development
 Table 58. Ferring Company Details
 Table 59. Ferring Business Overview
 Table 60. Ferring Assisted Reproductive Technologies Medications Product
 Table 61. Ferring Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 62. Ferring Recent Development
 Table 63. Organon Company Details
 Table 64. Organon Business Overview
 Table 65. Organon Assisted Reproductive Technologies Medications Product
 Table 66. Organon Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 67. Organon Recent Development
 Table 68. Solvay Company Details
 Table 69. Solvay Business Overview
 Table 70. Solvay Assisted Reproductive Technologies Medications Product
 Table 71. Solvay Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 72. Solvay Recent Development
 Table 73. Besins Company Details
 Table 74. Besins Business Overview
 Table 75. Besins Assisted Reproductive Technologies Medications Product
 Table 76. Besins Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 77. Besins Recent Development
 Table 78. Zhejiang Xianju Company Details
 Table 79. Zhejiang Xianju Business Overview
 Table 80. Zhejiang Xianju Assisted Reproductive Technologies Medications Product
 Table 81. Zhejiang Xianju Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 82. Zhejiang Xianju Recent Development
 Table 83. Changchun GeneScience Company Details
 Table 84. Changchun GeneScience Business Overview
 Table 85. Changchun GeneScience Assisted Reproductive Technologies Medications Product
 Table 86. Changchun GeneScience Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 87. Changchun GeneScience Recent Development
 Table 88. Hybio Pharmaceutical Company Details
 Table 89. Hybio Pharmaceutical Business Overview
 Table 90. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Product
 Table 91. Hybio Pharmaceutical Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 92. Hybio Pharmaceutical Recent Development
 Table 93. Livzon Pharmaceutical Company Details
 Table 94. Livzon Pharmaceutical Business Overview
 Table 95. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Product
 Table 96. Livzon Pharmaceutical Revenue in Assisted Reproductive Technologies Medications Business (2020-2025) & (US$ Million)
 Table 97. Livzon Pharmaceutical Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Assisted Reproductive Technologies Medications Picture
 Figure 2. Global Assisted Reproductive Technologies Medications Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Assisted Reproductive Technologies Medications Market Share by Type: 2024 VS 2031
 Figure 4. Down-Regulation Drugs Features
 Figure 5. Ovulation Stimulation Drugs Features
 Figure 6. Ovulation Inducing Drugs Features
 Figure 7. Luteal Support Medications Features
 Figure 8. Global Assisted Reproductive Technologies Medications Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Assisted Reproductive Technologies Medications Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Pharmacy Case Studies
 Figure 11. Specialty & Retail Pharmacy Case Studies
 Figure 12. Online Pharmacy Case Studies
 Figure 13. Assisted Reproductive Technologies Medications Report Years Considered
 Figure 14. Global Assisted Reproductive Technologies Medications Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Assisted Reproductive Technologies Medications Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Assisted Reproductive Technologies Medications Market Share by Region: 2024 VS 2031
 Figure 17. Global Assisted Reproductive Technologies Medications Market Share by Players in 2024
 Figure 18. Global Top Assisted Reproductive Technologies Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproductive Technologies Medications as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Assisted Reproductive Technologies Medications Revenue in 2024
 Figure 20. North America Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Assisted Reproductive Technologies Medications Market Share by Country (2020-2031)
 Figure 22. United States Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Assisted Reproductive Technologies Medications Market Share by Country (2020-2031)
 Figure 26. Germany Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Assisted Reproductive Technologies Medications Market Share by Region (2020-2031)
 Figure 34. China Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Assisted Reproductive Technologies Medications Market Share by Country (2020-2031)
 Figure 42. Mexico Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Country (2020-2031)
 Figure 46. Turkey Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Assisted Reproductive Technologies Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Merck Serono Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 50. Ipsen Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 51. Ferring Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 52. Organon Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 53. Solvay Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 54. Besins Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 55. Zhejiang Xianju Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 56. Changchun GeneScience Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 57. Hybio Pharmaceutical Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 58. Livzon Pharmaceutical Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Assisted Reproductive Technologies Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assistive Reproductive Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assistive Reproductive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Assisted Reproductive Apparatus Market Research Report 2025
Global Assisted Reproductive Treatment Market Research Report 2024
IVF Devices and Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproductive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Assisted Reproductive Medications Market Research Report 2024
Global Injectable Fertility Medications Market Research Report 2024
Global Injectable IVF Medications Market Research Report 2024
Global Infertility Treatment Drugs Market Insights Forecast to 2030
Global Fertility Enhancing Treatment Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Fertility Drugs Market Insights Forecast to 2030
Female Infertility Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IVF Service Market Research Report 2024
Global Infertility Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global IVF and ART Incubators Market Research Report 2024
Global IVF Software Market Insights Forecast to 2030
In Vitro Fertilization IVF Treatment Market
Assisted Reproductive Technology Drugs Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions